These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Zheng G; Huang L; Tong H; Shu Q; Hu Y; Ge M; Deng K; Zhang L; Zou B; Cheng B; Xu J Respir Res; 2014 Apr; 15(1):39. PubMed ID: 24708472 [TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. McAuley DF; Cross LM; Hamid U; Gardner E; Elborn JS; Cullen KM; Dushianthan A; Grocott MP; Matthay MA; O'Kane CM Lancet Respir Med; 2017 Jun; 5(6):484-491. PubMed ID: 28526233 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS. Wick KD; Leligdowicz A; Zhuo H; Ware LB; Matthay MA JCI Insight; 2021 Jun; 6(12):. PubMed ID: 33974564 [TBL] [Abstract][Full Text] [Related]
17. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosing Clinical Trial. Lightner AL; Sengupta V; Qian S; Ransom JT; Suzuki S; Park DJ; Melson TI; Williams BP; Walsh JJ; Awili M Chest; 2023 Dec; 164(6):1444-1453. PubMed ID: 37356708 [TBL] [Abstract][Full Text] [Related]
18. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Needham CJ; Brindley PG Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial. Pochon C; Laroye C; Kimmoun A; Reppel L; Dhuyser A; Rousseau H; Gauthier M; Petitpain N; Chabot JF; Valentin S; de Carvalho Bittencourt M; Peres M; Aarnink A; Decot V; Bensoussan D; Gibot S Front Med (Lausanne); 2023; 10():1224865. PubMed ID: 37706025 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial. Martínez-Muñoz ME; Payares-Herrera C; Lipperheide I; Malo de Molina R; Salcedo I; Alonso R; Martín-Donaire T; Sánchez R; Zafra R; García-Berciano M; Trisán-Alonso A; Pérez-Torres M; Ramos-Martínez A; Ussetti P; Rubio JJ; Avendaño-Solà C; Duarte RF Bone Marrow Transplant; 2024 Jun; 59(6):777-784. PubMed ID: 38409332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]